Achyut Healthcare Limited held a Board of Directors meeting on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27).
The meeting commenced at 16:00 PM and concluded at 16:40 PM, lasting 40 minutes. The board approved the unaudited financial results along with the limited review report from the statutory auditors.
The financial results were prepared in accordance with:
- Companies (Indian Accounting Standards) Rules, 2015 (as amended)
- Section 133 of the Companies Act, 2013
- Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
The company has only one reportable segment - Pharmaceuticals Business. Figures for previous periods have been regrouped, rearranged, or reclassified where necessary to correspond with current period classification.
Statutory auditors Doshi Doshi & Co (Firm Registration No.: 153683W) conducted a limited review of the financial results in accordance with Standard on Review Engagements (SRE) 2410. Partner Chintan R. Doshi (Membership No.: 158931) signed the review report, concluding that nothing came to their attention indicating material misstatement or non-compliance with disclosure requirements under SEBI Listing Regulations.
The disclosure was made pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document was signed by Managing Director Jigen J. Modi (DIN: 03355555) and digitally signed on August 13, 2026, at 16:43:19.
Financial Impact
Financial impact details from the results table were not fully legible in the provided data. The limited review report confirms compliance with accounting standards but does not provide specific financial figures.